MRC spin-off company engineering modified mice
A new multi-million pound company that specialises in producing genetically engineered mice with human diseases has been set up by two Medical Research Council scientists. Etiologics Ltd, which has initial venture capital backing of £3.5 million, was spun out of the MRC Mammalian Genetics Unit in Harwell, where frontline research is conducted into the genetic causes of disease.
Register to continue
Why register?
- Registration is free and only takes a moment
- Once registered, you can read 3 articles a month
- Sign up for our newsletter
Subscribe
Or subscribe for unlimited access to:
- Unlimited access to news, views, insights & reviews
- Digital editions
- Digital access to THE’s university and college rankings analysis
Already registered or a current subscriber? Login